Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
2,841 total articles
MGM looks attractively priced on an EV/EBITDA of ~6.4 with >$1.36B of free cash flow and a $10.0B market cap. Operational headwinds from 2025 have left sentiment muted, but recent strategic moves, digital/international growth opportunities and improving technicals support a long trade. Entry $36.00, stop $33.00, target $42.00 - horizon ~180 trading…
Hexcel (HXL) supplies advanced composite materials to aerospace, defense and industrial markets. With aircraft production rates rising and demand for carbon-fiber structures increasing, I expect Hexcel's earnings to ramp aggressively in FY2026. This is a tactical long idea with a defined entry at $83.21, stop at $72.00 and target at $105.00 on a 18…
Constellium is a high-beta aluminum producer with built-in pricing pass-through and targeted product investments into battery foilstock and aerospace alloys. We like a tactical long: entry $24.00, stop $21.00, target $30.00 over a mid-term horizon (45 trading days). The trade balances cyclical upside from aluminum and contract/procurement protectio…
Cadre Holdings is a makers-and-distributor of protective equipment that appears positioned to win a material share of rising nuclear safety and critical-infrastructure spend. Fundamentals show healthy cash flow and a clean balance sheet; valuation at $1.68B market cap still requires multiple compression to reflect slower growth, making the next con…
LUCMF is an OTC-listed junior mining name trading at $1.445 with constructive technicals (RSI 63, MACD bullish) and an elevated but falling short interest profile. With market attention on its ramp-up narrative and metals prices supportive, we favor a directional long trade over the mid-term (45 trading days) while acknowledging execution and liqui…
AbbVie reported solid Q4 2025 results on 02/04/2026 with $16.62B in sales and adjusted EPS of $2.71, driven by Skyrizi and Rinvoq offsetting Humira declines. The stock sold off despite the beat. Given a $388B market cap, nearly $20B in free cash flow, and technicals that have stabilized, a mid-term long trade with a defined stop and target offers a…
Kosmos (KOS) trades like a levered oil bet: cheap on headline multiples, operationally levered to production recovery and oil prices, and heavily shorted. For traders willing to accept elevated risk, a disciplined long with a clear entry, stop and target offers asymmetric upside if oil and project execution improve over the next 6-8 weeks.
Establishment Labs (ESTA) is transitioning from a high-growth rollout to operating leverage and potential profitability. The shares trade at a premium EV/sales multiple that already prices in continued adoption of Motiva implants, but recent revenue beats, healthy liquidity ratios and shrinking short-seller pressure create a mid-term long setup. Th…
Microsoft has been sold off with the broader software cohort, but fundamentals - $77.4B free cash flow, 30% ROE, and a fortress balance sheet - argue that current fears are more sentiment than reality. Technicals show oversold conditions and short interest that can fuel a bounce. This trade idea proposes a long with a measured stop and a long-term …
Netflix is trading near its 52-week low after a 40% pullback from peak. The story is straightforward: continued revenue and subscriber growth (2025 revenue +16% to $45B; 325M subscribers), healthy free cash flow ($9.46B) and a still-robust margin profile support a tactical long. Technicals are deeply oversold (RSI ~22.7) and valuation metrics (P/E …
Sandisk (SNDK) is not a momentum-only story. Recent results show 61% revenue growth, gross margins expanding toward mid-60s, and adjusted EPS power that help justify a higher multiple. Combine that with a lightweight short interest, strong technicals, and an enterprise value under $90B versus a market cap just over $100B, and the risk/reward favors…
Nu Holdings remains one of Latin America's best fintech franchises - fast revenue growth, improving profitability and 127 million customers. That said, at a market cap north of $83 billion, a compressed momentum backdrop, stretched multiple and a looming earnings event make current levels unattractive for new longs. This trade recommends a tactical…
ServiceNow is seeing real AI-driven demand — Now Assist already at $600M ACV and accelerating — while the market fixates on existential fears for the SaaS model. Fundamentals (free cash flow $4.58B, market cap $116B) and an oversold technical picture argue for a mid-term swing long. Entry $111.60, target $150.00, stop $98.00 — horizon 45 trading da…
PayPal plunged after weak Q4 results and a downgraded 2026 outlook, but fundamentals — $5.56B free cash flow, EV/EBITDA 5.4 and a sub-8x P/E — plus talk of double-digit buybacks make the post-crash level an actionable long with clearly defined entry, stop and targets across three horizons.
Constellium is trading near a fresh 52-week high on momentum tied to battery foil capacity and aerospace wins. Fundamentals show cyclical leverage and mixed cash flow, but valuation metrics (EV/EBITDA ~7.9; EV/Sales ~0.66) leave room for upside if the aluminum cycle holds. This is a mid-term swing trade: entry $24.30, target $28.00, stop loss $22.0…
Zeta Global (ZETA) has pulled back into a technically and fundamentally attractive entry. Strong revenue growth and improving free cash flow underpin a constructive view, while valuation metrics and bearish momentum call for a disciplined entry and tight risk controls. This trade plan targets a mid-term swing with clear entry, stop and target level…
Meta is trading below recent intra-week highs after an earnings-driven pullback. The company combines a strong ad business with accelerating AI investments and healthy cash flow. This trade idea sizes an entry at $670 with a $820 long-term target and a $620 stop, reflecting upside if AI-driven monetization and Reality Labs progress continue to outp…
SmartRent (SMRT) is a small-cap provider of smart-home hardware and property-management software that appears undervalued relative to the SaaS direction management is pushing. Current enterprise value implies roughly 1.4x sales while price-to-sales sits near 2.1x. With insider buying, no interest-bearing debt, and meaningful cash per share, the set…
Prediction-market entrants are real and deserve attention, but they are unlikely to materially disrupt FanDuel's sportsbook economics. Flutter's underlying cash flow, diversified segment mix, and the scale of its customer ecosystem justify a constructive, mid-term long trade on FLUT after the recent selloff.
Alamos Gold (AGI) offers a pragmatic long trade: a diversified three-mine producer, a market cap near $17.6 billion, and operational optionality that should benefit if gold stays firm. Multiples look distorted by current earnings and cash-flow swings, but valuation support from asset quality and a disciplined balance sheet make a mid-term long play…
Nvidia is moving past a pure semiconductor story toward an AI economics platform: GPUs remain the engine, but investments in cloud capacity deals, software stacks and guaranteed GPU take-or-pay arrangements are turning revenue into more predictable, higher-margin streams. The stock has pulled back into technical support and offers a risk-adjusted e…
Meta is trading well below its 52-week high despite strong ad revenue acceleration and explicit AI-driven guidance. The company’s balance sheet, cash generation, and improving operating momentum create a favorable risk-reward for a mid-term long. Trade plan included with entry at $670, stop at $620, and target at $780 over 45 trading days.
AbbVie's recent pullback after the 02/04/2026 quarter is a buying opportunity for a mid-term trade. Strong growth in Skyrizi and Rinvoq offset Humira's decline and produced 10% reported sales growth in Q4 2025; the market sold the stock on concerns about Humira erosion and aesthetics. Valuation is full but not frothy for a cash-generative pharma wi…
Symbotic reported a revenue beat in Q1 and raised guidance; with a reported multi-billion backlog and major retail customers racing to automate, the stock offers a mid-term long trade. Valuation looks rich on headline market cap but free cash flow and backlog conversion argue for upside if execution continues. Enter at $61.00, stop $50.00, target $…
MIELY looks positioned to outpace consensus in its next quarterly report thanks to strength in power systems, factory automation, and electronic devices. The stock shows bullish technicals and has run up from a $29.94 52-week low to a $69.85 high, but valuation still looks reasonable versus the recovery in profitability. This is a tactical long wit…
